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Background: The mechanisms of muscle injury repair after EPI® technique, a treatment based on electrical
stimulation, have not been described. This study determines whether EPI® therapy could improve muscle damage.
Methods: Twenty-four rats were divided into a control group, Notexin group (7 and 14 days) and a Notexin + EPI group.
To induce muscle injury, Notexin was injected in the quadriceps of the left extremity of rats. Pro-inflammatory interleukin
1-beta (IL-1beta) and tumoral necrosis factor-alpha (TNF-alpha) were determined by ELISA. The expression of receptor
peroxisome gamma proliferator activator (PPAR-gamma), vascular endothelial growth factor (VEGF) and vascular
endothelial growth factor receptor-1 (VEGF-R1) were determined by western-blot.
Results: The plasma levels of TNF-alpha and IL-1beta in Notexin-injured rats showed a significant increase compared
with the control group. EPI® produced a return of TNF-alpha and IL-1beta values to control levels. PPAR-gamma
expression diminished injured quadriceps muscle in rats. EPI® increased PPAR-gamma, VEGF and VEGF-R1 expressions.
EPI® decreased plasma levels of pro-inflammatory TNF-alpha and IL-1beta and increased anti-inflammatory PPAR-gamma
and proangiogenic factors as well as VEGF and VEGF-R1 expressions.
Conclusion: The EPI® technique may affect inflammatory mediators in damaged muscle tissue and influences the new
vascularization of the injured area. These results suggest that EPI® might represent a useful new therapy for the treatment
of muscle injuries. Although our study in rats may represent a valid approach to evaluate EPI® treatment, studies designed
to determine how the EPI® treatment may affect recovery of injury in humans are needed.
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Soft tissue injuries are recurrent in sports and have an
incidence rate of some 30% [1]. An overly conservative
therapeutic approach conflicts with patients’ economics
interests and the ability to practice their chosen sport.
Some authors have proposed qualitative and histopatho-
logical classifications of muscle injuries directly related
to the appearance of the lesion and its evolution [2].
The inflammatory process is one of the most import-
ant parts of the immune system’s response to injury. It is
due to the fact that the biochemical mechanism and the* Correspondence: drsanchez@cerede.es
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unless otherwise stated.signal cascade are consistent and durable, independent
of the underlying cause of the wound [3]. Non-muscle
cells such as leukocytes, phagocytes, macrophages, cyto-
kines or growth factors play an important role in the
inflammatory process in terms of recovery and regener-
ation following injury to the muscle as well as in the sec-
ondary damage that occurs during the inflammatory
process. Certain substances, such as interleukin 1-β
(IL-1β), released from the muscle injury act as intercellu-
lar messengers, start the process of inflammation and re-
pair [4]. Moreover, tumor necrosis factor-alpha (TNF-α)
is an important mediator of the inflammatory response
after injury [5] whereas activation of PPAR, an anti-
inflammatory protein, suppresses pro-inflammatory pro-
cesses [6,7]. As a result of muscle injury, localizedhis is an Open Access article distributed under the terms of the Creative
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through the release of histamines from the cells present
within the damaged area and by activating the route of
the vascular endothelial growth factor and nitric oxide
(VEGF-NO) [8]. VEGF is the most important capillary
growth factor in skeletal muscle [7] and is essential to
basal capillarization in the tissue and increased capillary
growth in response to different mechanical stimuli [9].
Electrical stimulations are likely to serve as an integra-
tor to organize cells into structured tissues in wound
healing, development and tissues regeneration. Because
cells possess signaling systems that make for electric
stimulation, the exogenous application of therapeutic cur-
rents for wound healing is considered to have effects as
well. The difficulties lie in the technical details such as types
of electrodes, stimulation parameters, stimulation position,
and the variability of intrinsic resistance [10].
The EPI® technique is an ultrasound guided physiothera-
peutic and medical technique that consists in causing, by
means of a galvanic current transmitted through an acu-
puncture needle, localized lysis in the damaged and/or
degenerated tissue [11-13]. The application of a galvanic
current brings about a chemical reaction, which causes the
dissociation of molecules of sodium chloride and water.
This process results in the formation of molecules of so-
dium hydroxide, which cause the destruction of the dam-
aged tissue and activate the inflammatory repair response.
The application of EPI® can stimulate the inflammatory re-
sponse and promote wound healing in degenerated patellar
tendon in rats [11] and has proven effective in the treat-
ment of chronic patellar tendinopathy [12,13].
Currently there is no published basic research relative
to the effect on muscle tissue injury upon applying this
treatment. Accordingly, the objective of this study was
to determine whether the application of EPI® therapy
could have a beneficial effect on damaged muscle. An
experimental design was carried out with the EPI® treat-
ment after 7 days of Notexin-induced injury. Notexin
has been described as inducing necrosis of skeletal
muscle fibers in experimental inflammation models.
Notexin, a presynaptic phospholipase A2 neurotoxin
isolated from snake venom, produced inflammatory
events associated with enzymatic activity and the re-
lease of arachidonic acid metabolites or mechanism
related to phospholipid hydrolysis [14].
The experimental hypothesis is that the application of
intratissue percutaneous electrolysis therapy after Notex-
ina induced muscle damage causes muscular effects that
may be conducive to the recovery of injured muscle
tissue.
Methods
Twenty-four Sprague-Dawley rats weighing 250-300g
were divided into four groups. To induce muscle injury,200 μl of Notexin was injected intramuscularly at a con-
centration of 10 μg/ml in the quadriceps of the left ex-
tremity, causing total degeneration of the muscle. As
control, a group of rats (n = 6) were injected with 200 μl
of saline solution. At seven days, rats were sacrificed and
samples were obtained to determine the effects of
Notexin-induced muscle injury. To study the effects of
EPI® treatment on tissue injury, a specific approved EPI®
device (EPI Advanced Medicine, Barcelona, Spain) was
used. The following protocol was performed: on day
seven of Notexin-induced muscle injury, one group of
rats (n = 6) were treated with EPI®. This treatment con-
sists in the application of a continuous current of 4
pulses at an intensity of 3 mA for 5 seconds conveyed to
the muscle. As an electrode, an acupuncture needle with
a diameter of 0.32 mm was used. To study how the in-
jury evolves without receiving EPI® treatment, another
group of rats (n = 6) was maintained dover 14 days after
Notexin-induced injury. Previous to each treatment, rats
were anesthetized intraperitoneally with sodium pento-
barbital (90 mg/kg). The evolution of the muscle tissue
injury was assessed by means of ultrasound images. The
same evaluations were carried out after seven days of
EPI® treatment. After the protocol, rats were sacrificed
and muscle tissue was removed from the treatment area
and samples were analyzed by using Western blot. Add-
itionally blood samples were collected to detect TNF-α and
IL-1β cytokines plasma levels with ELISA. The Ethical
Committee of the University of Medicine of Valencia, Spain
(A1301314899794) approved the study. All animal
procedures were carried out in accordance with the
European legislation on the use and care of laboratory
animals (CEE 86/609).
Ultrasonography was performed before and after
EPI® treatment to follow up on the muscle tissue in-
jury induced by Notexin (Figure 1). This examination
was performed according to the protocol previously
described [15].
Plasma levels of cytokines IL-1β and tumor necrosis
factor-α (TNF-α) were determined with ELISA kits
(Thermo Scientific Laboratories, Rockford, USA) follow-
ing manufactorer’s recommendations.
Muscle tissues were homogenized in a lysis buffer of
(in mM) 50 Tris-HCl, 125 NaCl, 1 EDTA, 1 EGTA and
1% Nonidet (NP-40 containing 5% Complete Mini-tab
cocktail proteinase inhibitor (Roche Biochemicals). It
was then centrifuged at 10000 rpm for 15 min at 4°C.
The protein concentration was determined using a
modified Lowry method. Protein was resolved in 12%
SDS-PAGE and electrophoretically transferred onto a
PVDF-membrane using a Mini Trans-Blot cell (BioRad
laboratories, California). Membranes were put in blocks
in 5% skim milk for 1 hour at room temperature and then
incubated with the corresponding antibodies following the
Figure 1 Comparison control tissue (A), muscle tissue 21 days after injury induction with Notexina (B) and the effect of the application of EPI®
from7 days of the induced lesion (C) in ultrasound imaging (US). It is possible to observe the area of disruption in the middle portion of the
quadriceps muscle of rats from 21 days of the induced lesion (surrounded area), compared to normal tissue from the same area (B). Image (C)
shows an area of less disruption in the same muscle portion treated with EPI® from 21 days after induction of injury (surrounded area).
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membranes were incubated with horseradish peroxidase-
conjugated secondary antibody (Sigma Aldrich). The blots
were then visualized using a InmunostarTM HRP Substrate
Kit (BioRad), again, in accordance with manufacturer’s in-
structions. The relative densities of the bands were analyzed
using Image Gauge v4.0, Fujifilm. The proteins were nor-
malized with tubulin. Monoclonal anti-vascular endothelial
growth factor (VEGF) (1:500), anti-vascular endothelial
growth factor receptor 1 (VEGF-R1) (1:500), anti-PPAR-γ
(1:500) and anti-tubulin (1:1000) were used.
For statistical analysis, data are expressed as mean ±
standard deviation (SD). An analysis of variance (ANOVA
factor) was performed to analyze the relationships within
and between variables. Post-Hoc and Dunnet tests
were also done to compare the different groups with
the control group and the Scheffe test was used to
compare all groups. A probability value of less than
0.05 was considered significant.
Results
Notexin produced tissue injury characterized as an an-
echoic ultrasound image with fluid collection corre-
sponding to a muscle lesion (Figure 2A). Treatment withFigure 2 Longitudinal ultrasound images of left rat quadriceps. After 7
collection (arrow) indicating muscle lesion was observed. After EPI® trea
repair (arrow) can be seen.EPI® produced resorption of the fluid and repair without
scar tissue thickening (Figure 2B).
The levels of TNF-α and IL-1β pro-inflammatory fac-
tors in Notexin injured rats showed a significant increase
(p < 0.05) in plasma concentration relative to the control.
In addition, a significant decrease in the concentration
of TNF-α and IL-1β was observed when the Notexin + EPI
group and the Notexin group (p < 0.05) were compared. So,
the application of the EPI® treatment after Notexin pro-
voked the decrease of both TNF-α and IL-1β to control
levels (Figure 3A and B). After 14 days of Notexin treat-
ment without EPI® application, the values of cytokines con-
tinued increased (Figure 3A and B). These results rule out
spontaneous recovery of the muscle damage.
Similarly, Notexin-induced injury decreases PPAR-γ
expression values (p < 0.05) in rat quadriceps muscle.
The application of EPI® increased PPAR-γ expression
and were returned to the values of the control, showing
that EPI® treatment produces an improvement in anti-
inflammatory PPAR-γ protein (Figure 4). Furthermore,
at 14 days of Notexin treatment without EPI® applica-
tion, PPAR-γ protein expression remains decreased, thus
indicating that an increase in PPAR-γ protein expression
is not spontaneous but due to the EPI® treatment.days treated with Notexin (A), an anechoic image with fluid
tment (B) a complete resorption of the haematoma with muscle
Figure 3 Plasma levels of IL-1β (A) and TNF-α (B) in control (C), Notexin (N7d, N14 d) and Notexin + EPI (N + E) groups. Values were measured by
ELISA assay as indicated in methods. Data are mean ± SD of six independent experiments. *p < 0.05 vs control group; # p < 0.05 vs both
Notexin groups.
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crease in both VEGF and VEGF-R1 protein expression
compared with the control (p < 0.05). Furthermore, EPI®
treatment significantly potentiated the increase in VEGF
and VEGF-R1 protein expression induced by Notexin
(Figure 5).
No adverse events were presented during the study.
Discussion
The main findings of this study is that EPI® applied after
Notexin-induced muscle injury in rats decreases the
production of the inflammatory mediators TNF-α and IL-
1β, increases the protein expression of anti-inflammatory
factor PPAR-γ and the angiogenic involved proteins VEGF
and VEGF-R1.
An increase in the TNF-α plasma levels was described
in the first days of tissular injury [16,17] and remained
elevated due to its action on cellular necrosis [18]. TNF-
α disrupts the differentiation process and can promote
cell catabolism thereby accelerating protein degradation
[5]. Furthermore, TNF-α inhibits myogenesis through
redox-dependent and independent pathways [19]. OneFigure 4 PPAR-γ protein expression (relative densitometric units) in contro
were determined in left rat quadriceps muscles by Western blot. A represe
of protein. Data are mean ± SD of six independent experiments. *p < 0.05 vpotential mechanism by which TNF-α might directly
stimulate catabolism is by inhibiting myoblast differenti-
ation, an action that might limit the regenerative re-
sponse of satellite cells to muscle injury [5]. A second
mechanism, apoptosis, appears less important. The third
mechanism consists in a direct catabolic effect on
muscle tissue. In a muscular cell culture, TNF-α directly
decreases total muscle protein and the loss of muscle-
specific proteins, including adult fast-type myosin heavy
chain [5,19].
Our data shows an increase in the plasma level of
TNF-α due to Notexin-induced injury. EPI® treatment
normalized the levels of TNF-α to reach control group
values. By contrast, in the group of rats without EPI®
treatment, the TNF-α levels remained elevated with re-
spect to the control group at 14 days after application.
TNF-α action is also sensitive to other ligand/receptor
interactions (e.g. interleukin-1 and interleukin-6). Notexin
caused a significant increase of IL-1β compared to the con-
trol group. The maintenance of IL-1β over time has been
associated with its condition as a pro-inflammatory cyto-
kine more than for its action on tissue necrosis [16].l (C), Notexin (N7d, N14 d) and Notexin + EPI (N + E) groups. Values
ntative inmunoblot is shown and tubulin was used as control amount
s control group; # p < 0.05 vs both Notexin groups.
Figure 5 Analysis of VEGF and VEGF-R1 proteins. VEGF (A) and VEGF-R1 (B) protein expression in control (C), Notexin (N7d, N14 d) and Notexin +
EPI (N + E) groups were determined by Western blot. Values were determined in left rat quadriceps muscles. In each panel, a representative
inmunoblot is shown and tubulin was used as control amount of protein. Data are mean ± SD of six independent experiments. *p < 0.05 vs
control group; # p < 0.05 vs both Notexin groups.
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in skeletal muscle [20]. EPI® treatment returns IL-1β plasma
levels to normal values. On the contrary, after 14 days of
application without EPI®, the levels of IL-1β remain signifi-
cantly high compared to control values. Taken together, the
results indicate that EPI® treatment is effective in diminish-
ing pro-inflammatory mediators. Further studies are needs
to determine the mechanisms involved in the inflammatory
effects of EPI® treatment. Besides that, EPI® decreases pro-
inflammatory mediators and anti-inflammatory proteins
may also be activated. PPAR-γ has been recognized as play-
ing a fundamental role in the immune response through its
ability to decrease the expression of pro-inflammatory
genes [21]. It also increases the expression levels of
genes that are involved in anti-inflammatory effects and
tissue repair [22,23]. Furthermore, PPAR-γ induces the
expression of VEGF and its receptors in cultured
cardiac myofibroblasts [24]. Our data indicated that
Notexin produced a significant decrease in PPAR-γ
protein expression, similar at 7 and 14 days, compared
with control. EPI® treatment significantly increases
PPAR-γ protein expression reduced by Notexin and
returns levels to control values. In addition, PPAR-γ
promotes the myocellular storage of energy by increasing
fatty acid uptake and esterification while simultaneously en-
hancing insulin signaling and glycogen formation, which
have beneficial effects on metabolic health and therefore on
tissue repair [25].
Electrical stimulation has multiple effects in directing
cell division, vascular endothelial cells, angiogenesis and
endothelial migration, all of which are important
elements in wound healing [10]. Vascular endothelialgrowth factor (VEGF) is a paracrine factor. Its main
function is to promote angiogenesis by improving cellu-
lar survival, inducing proliferation and enhancing the
migration and invasion of endothelial cells. Skeletal
muscle fibers can control capillary growth by releasing
VEGF from intracellular vesicles during contraction [26].
Recent evidence suggests that VEGF has effects on skel-
etal muscle regeneration by stimulating the myogenic
differentiation of muscle-derived stem cells [27,28].
Our results indicate a clear induction of VEGF protein
expression after Notexin-induced damage. These results
are in accordance with a greater production of VEGF in
damaged tissue than in normal tissue [29]. Furthermore,
VEGF-R1, the more actively induced receptor by tissue
injury, is also increased as has been described in
trauma patients [30]. EPI® treatment further signifi-
cantly increases both VEGF and VEGF-R1 thus sug-
gesting an active role in maintaining blood flow in the
microcirculation and also may increase the systemic
level of soluble anti-inflammatory and cytoprotective
mediator events that can improve the recovery from
injury [30].
Despite the many treatments proposed to treat muscle
injuries, the rate of re-injury is still very high. This is
probably due to the fact that a greater understanding
and analysis of the type, size and location of the lesion
in each case [31] is required.
Some authors argue that the size of the lesion corre-
lates with the time the patient will need to return to
competition [32]. By contrast, other study groups sug-
gest that neither the presence of ultrasound findings nor
the size of them correlate with the time needed to return
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ies should not be guided by these results alone [33,34].
Although the number of cases may be considered low,
the difference between the variables studied was very
high. Therefore, sufficient power was obtained so as to
detect differences with a significance ranging from 55 to
58% for VEGF and VEGF-R1 variables as well as from
88% to 100% in TNF and IL-1B variables.
The work has some limitations such as the use of rats.
As such, it might not be possible to extrapolate the result
to humans. In spite of that possibility, rats have been used
in many valid experimental studies [14-17,20,27]. Another
limitation is the lack of a histological or functional evalu-
ation, which could give physiological relevance to the inter-
pretation of the data presented [35]. The electrolysis and/or
sodium hydroxide produced by the EPI® technique may
interfere with IL-1beta and TNF-alpha values, affecting the
existing cytokines. Therefore, we wait 7 days after the EPI®
technique application to see its beneficial effects. Cytokines
from the cells at the local position will be produced
chronically and maintained over time when inflamma-
tion and damage is present. We detect a reduction
of pro-inflammatory cytokines after EPI® induction.
Thus, cells are probably in a state of less inflammation
with less cytokine production in comparison to cells
without the EPI® technique.
Despite the limitations exposed, the present work is
the first investigation on the effect of EPI® on muscle tis-
sue that shows the biomolecular mechanisms triggered
by the application of the same. This experimental work
is the basis upon which clinical trials to confirm the ef-
fectiveness of the EPI® in humans should be developed.
Conclusion
The application of EPI® on rat muscle previously in-
jured with Notexin causes a significant decrease in
pro-inflammatory mediators like TNF-α as well as
IL-1β levels. On the other hand, the application of
EPI® produced an increase in the expression of anti-
inflammatory proteins (PPAR-γ) and also increases
VEGF and VEGF-R1 expression. Therefore, the use of
EPI® may affect inflammatory mediators in damaged
muscle tissue and influence the new vascularization of
the injured area. These results suggest that EPI® might
represent a useful new therapy for the treatment of
muscle injuries.
Although our study in rats may represent a valid
approach to evaluate EPI® treatment, studies designed to
determine how EPI® treatment may affect recovery of
injury in humans are needed.
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